The Most Exciting Time to Be Investing in Life Sciences in a Generation

In 20 20, 430 some million a to put to work in biotet companies. Technology convergence and maturity is now truly unprecedented ime. There isn't nearly enough availability of prence management teams as they should be. People have learned how to develop these drugs or raise capital that wasn't always the case.